Alexandre Sepriano, Sofia Ramiro, Robert Landewé, Désirée van der Heijde, Sarah Ohrndorf, Olivier FitzGerald, Marina Backhaus, Maggie Larché, Joanne Homik, Alain Saraux, Hilde B Hammer, Lene Terslev, Mikkel Østergaard, Gerd Burmester, Bernard Combe, Maxime Dougados, Carol Hitchon, Gilles Boire, Robert G Lambert, Rana Dadashova, Joel Paschke, Edna J Hutchings, Walter P Maksymowych
OBJECTIVE: To assess whether using ultrasound (US) in addition to clinical information versus only clinical information in a treat-to-target (T2T) strategy leads to more clinical remission and to less radiographic progression in RA. METHODS: Patients with RA from the 2-year prospective BIODAM cohort were included. Clinical and US data (US7-score) were collected every 3 months and hands and feet radiographs every 6 months. At each visit, it was decided whether patients were treated according to the clinical definition of T2T with DAS44 remission as benchmark (T2T-DAS44)...
April 29, 2024: Clinical Rheumatology